Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02388685 · ClinicalTrials.gov registry record · NA

Comprehensive Magnetic Resonance in Peripheral Arterial Disease.3

A NA study, sponsored by University of Virginia.

Terminated
Registry status
NA
Development phase
16
Enrollment target

NCT02388685: Clinical Trial NA study, sponsored by University of Virginia.

NCT02388685 is a NA study that was terminated before completion, run by University of Virginia. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02388685, a NA study, was terminated before completion, sponsored by University of Virginia.

TERMINATED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

The goal is to test the ability to detect improved calf muscle perfusion and energetics in PAD patients in a randomized controlled trial of home exercise therapy. Eighty patients will be randomized to a 12 week home exercise program or no program (control).

Primary Outcome

Arterial spin labeling MRI at peak exercise

Interventions

  • OTHER Exercise

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2014-07
Est. Completion 2023-11-22
Phase NA
University of Virginia

449 total trials

Why NCT02388685 stopped before completion

NCT02388685 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.

NCT02388685 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02388685 about?

NCT02388685 is a clinical study titled "Comprehensive Magnetic Resonance in Peripheral Arterial Disease.3". The goal is to test the ability to detect improved calf muscle perfusion and energetics in PAD patients in a randomized controlled trial of home exercise therapy. Eighty patients will be randomized to a 12 week home exercise program or no program (control).

What is the current status of trial NCT02388685?

This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2014-07. Estimated completion is 2023-11-22.

What interventions are being tested in trial NCT02388685?

The interventions under investigation include: Exercise (OTHER).

Who is sponsoring clinical trial NCT02388685?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02388685's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02388685, the US trial registry maintained by the National Library of Medicine. NCT02388685 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.